Product Information
ROFLUMILAST 500 MCG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.3204 per EA under NDC 00904748389. Its NADAC has been published 56 times since Jun 4, 2025.
Strength
500 ug/1
Manufacturer
Major PharmaceuticalsNDC
00904748389
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ROFLUMILASTApproval Type
Generic (ANDA)
FDA Application
ANDA208256On Market Since
5/22/2024
Pharmacological Classes
Price Statistics
The NADAC for ROFLUMILAST 500 MCG TABLET has been published 56 times since Jun 4, 2025, and over the history we have for it it has declined 8.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3204 per EA |
|---|---|
| All-time high | $0.3654 (Jul 16, 2025) |
| All-time low | $0.3118 (Mar 18, 2026) |
| 52-week high | $0.3654 |
| 52-week low | $0.3118 |
| Median price | $0.3247 |
| Average price | $0.3324 |
| Largest weekly change | -8.9% (Sep 17, 2025) |
| Weeks tracked | 56 |
| Tracking since | Jun 4, 2025 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ROFLUMILAST 500 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROFLUMILAST 500 MCG TABLET, manufactured by Major Pharmaceuticals, is $0.3204 per EA (NDC 00904748389), effective Jun 24, 2026.
How has the price of ROFLUMILAST 500 MCG TABLET changed over time?
Over the history we have for it, the NADAC for ROFLUMILAST 500 MCG TABLET has declined 8.2%. It has been tracked across 56 weekly CMS publications since Jun 4, 2025.
What are the highest and lowest recorded NADAC prices for ROFLUMILAST 500 MCG TABLET?
Since Jun 4, 2025, the NADAC for ROFLUMILAST 500 MCG TABLET has ranged from a low of $0.3118 (Mar 18, 2026) to a high of $0.3654 (Jul 16, 2025), with a median of $0.3247 per EA.
Are there cheaper alternatives to ROFLUMILAST 500 MCG TABLET?
7 NADAC-published products share the same active ingredient, strength, and dosage form as ROFLUMILAST 500 MCG TABLET, but none are currently priced below it.
Who manufactures ROFLUMILAST 500 MCG TABLET?
ROFLUMILAST 500 MCG TABLET (NDC 00904748389) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification